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Abstract
Background: Due to a rising number of deaths from cancer and other chronic diseases a growing number of people
experience complex symptoms and require palliative care towards the end of life. However, population-based data on the
number of people receiving palliative care in Europe are scarce. The objective of this study is to examine, in four European
countries, the number of people receiving palliative care in the last three months of life and the factors associated with
receiving palliative care.
Methods: Cross-national retrospective study. Over two years (2009–2010), GPs belonging to representative epidemiological
surveillance networks in Belgium, the Netherlands, Italy, and Spain registered weekly all deaths of patients ($18 years) in
their practices and the care they received in the last three months of life using a standardized form. Sudden deaths were
excluded.
Results: We studied 4,466 deaths. GPs perceived to have delivered palliative care to 50% of patients in Belgium, 55% in Italy,
62% in the Netherlands, and 65% in Spain (p,.001). Palliative care specialists attended to 29% of patients in the
Netherlands, 39% in Italy, 45% in Spain, and 47% in Belgium (p,.001). Specialist palliative care lasted a median (inter-
quartile range) of 15 (23) days in Belgium to 30 (70) days in Italy (p,.001). Cancer patients were more likely than non-cancer
patients to receive palliative care in all countries as were younger patients in Italy and Spain with regard to specialist
palliative care.
Conclusions: Although palliative care is established in the countries studied, there are considerable differences in its
provision. Two potentially underserved groups emerge non-cancer patients in all countries and older people in Italy and
Spain. Future research should examine how differences in palliative care use relate to both patient characteristics and
existing national health care policies.
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Introduction
It is estimated that, in Europe, 4.8 million people die every year.
Approximately two million die from serious chronic disease and
cancer, with a further increase in deaths from these causes
expected [1]. Given that a growing proportion of people will live
into old and very old age, and that chronic diseases are more
common in old people, an increasing number of people will be
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living with the effects of these illnesses [2,3]. The burden that these
demographic and epidemiological developments place on society
has been recognized by the World Health Organization (WHO)
and the European Union who have identified care for people at
the end of life as an important public health issue [4,5].
People dying from cancer and other serious chronic diseases are
very likely to experience multiple and complex symptoms
requiring appropriate and timely assessment and treatment, and
thus are in potential need of palliative care [2]. The WHO defines
palliative care as ‘‘…an approach that improves the quality of life
of patients and their families facing the problem associated with
life-threatening illness, through the prevention and relief of
suffering by means of early identification and impeccable
assessment and treatment of pain and other problems, physical,
psychosocial and spiritual.’’ [4] Population-based data on the
number and characteristics of people who access palliative care in
Europe are limited. Particularly little is known about the
characteristics of people who do not receive palliative care, and
about the extent to which palliative care is delivered to those dying
from illnesses other than cancer, who are likely to be underserved
[6,7]. Obtaining this information is essential for ensuring the
adequate organisation and provision of palliative care on national
levels, and its integration into mainstream health care services.
In recent years major efforts have been undertaken to assess the
establishment of palliative care within health care systems around
the world, including the availability of palliative care services,
funding arrangements and policy support [8–11]. While these
studies provide valuable knowledge about the development of
palliative care, they do not provide information on the actual
percentage of people at the end of life receiving it nor about the
timing of initiation of palliative care before death. Other studies
have focussed on single countries only or have selectively studied
patients with cancer or those in particular care settings, thereby
precluding a population-based perspective on the use of palliative
care [12–15]. Studies estimating population coverage solely on the
basis of annual activity data of palliative care services risk double-
counting, since unique patient codes are not used across health
care settings. Additionally, due to differences in research design,
these single studies cannot be compared across countries.
We have conducted one of the first population-based studies
assessing and comparing the frequency and timing of use of
palliative care in a representative sample of the general population
of patients at the end of life in four European countries. Earlier
studies in Belgium and the Netherlands have successfully applied a
similar design, but did not explicitly assess whether GPs delivered
palliative care nor the length of time over which patients received
palliative care [16–18]. We have extended the study design to
include two more countries, Italy and Spain, and have assessed the
delivery of palliative care by GPs and by specialist palliative care
services as well as the time of initiation.
This study aimed to address the following research questions
with regard to the last three months of life of patients who died
non-suddenly in Belgium, the Netherlands, Italy and Spain:
How many people receive palliative care from their GP and
through specialist palliative care services, and are there differences
between countries?
For how many days during the last three months of life do
people receive specialist palliative care, and are there differences
between countries?
Are patients’ sex, age, cause and place of death associated with
the use of palliative care delivered by the GP and the use and time
of initiation of specialist palliative care?
Methods
Ethics Statement
Informed consent and patient and GP anonymity. The
participating GPs gave written informed consent at the beginning
of each registration year, after being fully informed about the
objectives and methods of the study. Strict procedures regarding
patient anonymity were followed during data collection and entry.
Each registered death received an anonymous reference from the
GP. Any potentially identifying patient and GP data (such as
patient’s date of birth, postcode, and GP identification number)
were replaced by aggregate categories or anonymous codes. In
Belgium and the Netherlands, patients of GPs who were part of
sentinel networks were informed through posters or leaflets
displayed in the practices that their data could be used
anonymously for research purposes. In Italy, patients are informed
that their care-related data, when anonymised, can be used to
monitor care as standard. Patients in Spain were not necessarily
informed that their data could be used for research. However, as
all data were thoroughly anonymised, this was not required. The
proceedings in each country comply with the country’s respective
laws [19–25].
Ethics approval. Ethics approval for this study, including the
consent procedure, was obtained from the Ethical Review Board
of Brussels University Hospital of the Vrije Universiteit Brussel,
Belgium (2004), and from the Local Ethical Committee ‘Comitato
Etico della Azienda U.S.L. n. 9 di Grosseto’ in Tuscany, Italy
(2008). Ethics approval was not required for posthumous collection
of anonymous patient data in the Netherlands [19,20] or Spain
[21–23], according to the legislation of these countries.
Study Design
This study is part of the EURO SENTIMELC (European
Sentinel Network Monitoring End-of-Life Care) study, a cross-
national retrospective study monitoring end-of-life care in
Belgium, the Netherlands, Italy, and Spain (the Castile and Leon
and Valencian Community regions) [26]. Data were collected
through representative sentinel networks of GPs who continuously
registered all deaths amongst patients in their practices. GP
sentinel networks are epidemiological surveillance networks
consisting of freestanding practices or community-based physicians
who voluntarily and continuously monitor health problems
occurring in the population. They have a long-standing involve-
ment in epidemiological research, a low annual turnover, and
were shown to be suitable for monitoring health-related epidemi-
ological data [27–29]. In Belgium, the Netherlands, and Spain we
cooperated with existing long-standing sentinel networks that
monitor a wide range of health problems, whereas in Italy a new
network was formed for this study as the existing network had a flu
surveillance focus. GPs are recruited into the sentinel networks by
national public health institutes, who draw a random sample of
GPs and invite them to become part of the network. The new
Italian network was created by the Italian Society of General
Practitioners through a procedure similar to that in the other
countries. The Italian GPs were recruited from nine health
districts that are spread all over the country. At the point of
recruitment, GPs were informed only about the procedure and not
about the subject of the surveillance in order to avoid an
overrepresentation of GPs with a particular interest in palliative
care. In each country the institutes responsible for creating the
sentinel networks verified that the sentinel GPs were representative
of the total GP population in terms of age, sex, and geographic
location. The number of participating GPs and their population
coverage per country in 2009 was as follows: 199 (1.8%) in
Palliative Care Use in Four European Countries
PLOS ONE | www.plosone.org 2 December 2013 | Volume 8 | Issue 12 | e84440
Belgium, 59 (0.8%) in the Netherlands, and 149 (4.3%) in Italy. In
Spain, data were collected in 2010 only. The respective figures for
2010 are 189 (1.5%) in Belgium, 63 (0.8%) in the Netherlands, 94
(2.7%) in Italy, and 173 in Spain (114 (3.8%) in Castile and Leon,
59 (2.2%) in the Valencian Community). The percentages in Italy
refer to the population of the nine participating health districts.
The percentages in Spain refer to the population aged 18 years or
over. The participating GPs of all four countries had an adequate
geographical distribution and were representative of the general
population of GPs in the respective country (or region in Spain)
with regard to sex and age [26]. This study protocol has been
successfully implemented in a number of cross-national compar-
isons [17,30–32]. Further information on the sentinel networks of
GPs and the methods of the study is provided in the published
study protocol [26].
Sample
Deaths of all patients 18 years or older in the participating GP
practices were included. Deaths classified by the GP as sudden and
totally unexpected, and those for which this information was
missing, were excluded in order to obtain a sample of patients for
whom palliative care was a relevant consideration [33,34]. This
criterion was chosen following a careful consideration of its
methodological strengths and limitations [34], and was based on
the fact that several studies in the palliative care literature
distinguish between sudden and non-sudden deaths [33–36].
Furthermore, nursing home deaths in the Netherlands were
excluded, as these patients are not cared for by GPs but by
specialised nursing home physicians.
Procedure
Using a standardised form GPs belonging to the sentinel
networks registered weekly all deaths among patients in their
practice who were aged 18 years or over throughout a two year
period, from Jaunary 1st 2009 to December 31st 2010 (in Spain
over one year, in 2010). At the beginning of each year, GPs
received instructions, clearly stating the inclusion criteria of the
study and how to complete the registration form.
Measurement
The registration form consists of structured and closed-ended
items surveying care-related information about the patient’s final
three months of life. The literature suggests that this is a relevant
time period for studying end-of-life care [33,37,38]. The
registration form was initially developed in Dutch and French
and translated into English. From English it was subsequently
translated into Italian and Spanish. All translations were carried
out via forward-backward procedure. The following items of the
registration form were included in the present study:
Dependent variables:
The GPs’ perception of whether she or he had delivered
palliative care to the patient : ‘did you provide palliative care to
this patient?’.
Specialist palliative care: ‘which palliative care initiatives were
involved in the last 3 months of this patient’s life?’ GPs were asked
to indicate which palliative care initiatives from a list of options
were involved in the patient’s care (these options differed between
countries due to differences in the services that are available, see
Table 1). The terminology used to label these services corresponds
to the labels commonly used in primary care in the respective
countries.
Time of initiation of specialist palliative care: ‘estimate the
number of days between the first palliative intervention and the
moment of death’.
Independent variables:
Age at death and sex.
Cause of death: ‘illness or disorder that was the direct cause of
death’.
Place of death: (a) home/living with family, (b) care home/
home for the elderly/nursing home, (c) hospital (excl. palliative
care unit and nursing home unit in a hospital), (d) palliative care
unit/hospice, (e) elsewhere (specified).
As the types of specialist palliative care services differ between
countries, they were classified into five categories to facilitate
comparison (Table 1).
While the geographic distribution of palliative care services is
relatively homogenous in Belgium and the Netherlands, there is
large heterogeneity in Italy and Spain. In Italy, the density of
palliative care services is higher in the north of the country
compared to the south, and in Spain there is great variation in the
organisation of palliative care between the different Autonomous
Communities. Furthermore, the countries differ with regard to the
role of GPs within palliative care services. In the Netherlands and
Belgium GPs are seen as the main care providers for people
requiring palliative care [39,40] and in Spain they are core
providers of palliative care in the community [41]. However, there
is uncertainty about the role of GPs within specialist palliative care
teams in Italy, perhaps due to the heterogeneity of organizational
models in the country [42].
Statistical Analysis
We carried out x2-tests to analyse differences in sex, age, cause
and place of death between the samples of the countries studied.
The place of death category ‘other’ was not included in the
significance tests in case of cell frequencies below 5.
Binary multivariate logistic regression analyses, adjusted for age,
sex, cause and place of death, were computed to assess the
association between country as the independent variable and
receiving palliative care by the GP and specialist palliative care as
dependent variables. A further binary multivariate logistic
regression analysis, adjusted for age, sex, cause and place of
death, was computed to compare between countries the number of
patients attended to by different specialist palliative care services.
The number of days during which specialist palliative care was
provided in the last three months of life was analysed both as a
continuous and as a categorical variable. The categories were (1)
1–3 days, (2) 4–7 days, (3) 8–30 days, and (4) 31–92 days. The
continuous variable was compared between countries using the
Kruskal-Wallis test. A multivariate ordinal logistic regression
analysis, adjusted for age, sex, cause and place of death, was
conducted to test the association between country and the four
categories of time of initiation.
For each country two binary multivariate logistic regression
analyses were computed to test whether age, sex, cause and place
of death are associated with receiving palliative care by the GP
(first analysis) or specialist palliative care services (second analysis).
Finally, a multivariate ordinal logistic regression analysis was
computed for each country to test whether the same factors are
associated with time of initiation of specialist palliative care.
For each multivariate logistic regression analysis commonly
recommended assumptions were tested [44]. Odds ratios and
binomial 95% confidence intervals were calculated for all
dependent variables and p-values for all tests of significance. All
statistical tests were performed with a significance level of a ,0.05
in IBM SPSS Statistics (version 19). If the percentage of missing
values was below 10%, cases with missing values on a particular
variable were omitted in analyses involving the respective variable.
In case it amounted to more than 10% we tested whether the
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proportion of missing values was significantly associated with
patients having received palliative care.
Results
Sample Characteristics
In total, 6,858 deaths were reported, of which 4,518 (65.9%)
were classified by the GPs as expected or non-sudden. The
percentage of deaths judged as non-sudden per country was as
follows: 67% in Belgium, 62% in the Netherlands, 66% in Italy,
69% in Spain (p,.001). These percentages of non-sudden deaths
are in line with those reported by physicians in previous studies
with a similar methodology [33–36]. Following the exclusion of
nursing home deaths from the Netherlands (n = 52, 7.6% of all
deaths registered in the Netherlands) a sample of 4,466 deaths
remained of which 1,604 were registered in Belgium, 635 in the
Netherlands, 1,839 in Italy, and 388 in Spain. The samples of the
registered non-sudden deaths from Belgium and the Netherlands
(excluding nursing home deaths) were compared to those of
previous death certificate studies in which representative samples
of non-sudden deaths were obtained [38,45]. For Italy and Spain,
the sample of all registered deaths was compared with national
mortality statistics. We did not find large differences, except for a
slight underrepresentation of non-sudden hospital deaths and
people under the age of 65 in Belgium and women in the
Netherlands [26].
Differences between countries in terms of sex, age, cause and
place of death were statistically significant (Table 2). The Dutch
sample revealed the smallest percentage of people aged 85 years or
over and the highest percentage of cancer deaths. In Spain there
was a relatively larger number of men and lower number of
women compared with the other countries. In Belgium, most
people died in hospital, whereas home was the most frequent place
of death in the other countries.
Palliative Care Provision by GPs
GPs stated they had delivered palliative care themselves to 50%
(Belgium), 55% (Italy), 62% (Netherlands), and 65% (Spain) of
patients (p,.001) (Table 3). GPs in Spain indicated that they had
delivered palliative care to significantly more patients than GPs in
Italy and Belgium. No statistically significant difference emerged
between GPs’ reports in Spain and the Netherlands.
Use and Duration of Specialist Palliative Care Services
Varying by country, 47% (Belgium), 29% (Netherlands), 39%
(Italy), and 45% (Spain) of patients received specialist palliative
care in the last three months of life (p,.001) (Table 3). This
percentage was significantly higher in Belgium, Spain, and Italy
compared to the Netherlands. The median number of days (and
inter-quartile range) over which specialist palliative care was
received in the last three months of life was 15 (23), 21 (53), 26 (53),
and 30 (70) in Belgium, the Netherlands, Spain, and Italy,
respectively (p,.001). The four countries differed significantly
with regards to the percentage of patients cared for in the different
specialist palliative care settings (Table 4). In Italy and Spain
specialist palliative care was mostly delivered through services for
patients residing at home (for 24% and 29% of patients,
respectively), in Belgium for patients residing at home and in a
Table 1. Classification of specialist palliative care services and healthcare professionals involved in these services.
Category Belgium Netherlands Italy Spain
Hospice/palliative
care unit
Palliative care unit in a
hospital: physician and
nurses; can call on the
support of other
professionals (psychologists,
social workers, etc.)
Hospice, palliative care unit
(in a hospital, nursing home,
or care home): palliative care
nurses, volunteers, patient’s
GP, sometimes hospice doctor
or other medical specialist
Hospice: physicians and
nurses specialised in
palliative care, can call on
the support of other
professionals (psychologists,
social workers, etc.)
Palliative care unit in a hospital:
physicians and nurses specialised
in palliative care, psychologist
Palliative care
service for patients
staying at home
Palliative home care team:
one GP, two nurses, one
secretarial assistant. Their
aim it is to advise front-line
carers.
Palliative day care centre:
physician, palliative care
nurses, volunteers
Palliative care consultation
team: consult all professionals
involved in palliative care;
consist of palliative care nurses,
GPs, nursing home physicians,
and other medical specialists,
all with extra training or
expertise in palliative care*
Palliative home care team:
physician and nurse
specialised in palliative
care; limited contact with
GPs. Domiciliary integrated
assistance with palliative
care: GP and nurse
Palliative home care team: GP,
nurse, social worker,
psychologist. Palliative day care
centre: GP and nurse.
Ambulatory palliative care in a
hospital: physicians and nurses
specialised in palliative care
GP with formal palliative
care training
1 GP with palliative
care training{
1 1
In-house palliative
care service in a
nursing home
Reference persons for palliative
care in a nursing home: aim to
support GPs and nurses
operating in the nursing home
1 1 Palliative care nurses in a nursing
home
Hospital-based
palliative care
service (excl.
palliative care unit)`
Mobile palliative care
support team in a hospital:
mobile team operating within
the hospital, consisting of
specially trained staff physicians,
nurses, and paramedics
Palliative care consultation
team (see above)*
Pain therapy or palliative
care specialist consultation
during a hospital admission:
physicians specialised in
palliative care
1
*Palliative care consultation teams offer services to patients at home as well as to patients in hospital/hospice/nursing home. Seventy-seven per cent of those for whom
palliative care consultation is requested are cared for at home [43].
{GPs who followed a ‘training in palliative care for general practitioners with an advisory role’ offered by the Dutch Association of General Practitioners (Nederlands
Huisartsen Genootschap, NHG) and who are registered as palliative care advisors in a central database.
`For patients admitted to hospital for at least one day in the last three months of life.
1No specialist palliative care initiatives available.
doi:10.1371/journal.pone.0084440.t001
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nursing home (16% of patients in each setting) and in the
Netherlands for those residing in a hospice or palliative care unit
(14%) or receiving care from a GP with palliative care training
(12%). The lowest proportion of patients to receive hospital-based
palliative care services, not including those in palliative care units,
was found in the Netherlands (1%).
Table 2. Characteristics of non-sudden deaths in Belgium, the Netherlands, Italy and Spain; % (95% CI), n.
Patient characteristics Belgium Netherlands Italy Spain p-value
N=1604 N=635 N=1839 N=388
Sex .04*
Male 46 (44 to 48) 47 (43 to 51) 47 (45 to 49) 54 (49 to 59)
731 295 856 209
Female 54 (52 to 56) 53 (49 to 57) 53 (51 to 55) 46 (41 to 51)
868 333 983 179
Age at death ,.001*
18–64 y 14 (12 to 16) 18 (15 to 21) 13 (11 to 15) 11 (8 to 14)
219 117 233 43
65–84 y 47 (45 to 49) 50 (46 to 54) 47 (45 to 49) 45 (40 to 50)
753 318 860 174
$85 y 39 (37 to 41) 32 (28 to 36) 40 (38 to 42) 44 (39 to 49)
620 200 746 171
Cause of death ,.001*
Cancer 37 (35 to 39) 53 (49 to 57) 46 (44 to 48) 39 (34 to 44)
595 335 830 149
Cardiovascular
diseases
15 (13 to 17) 15 (12 to 18) 21 (19 to 23) 16 (12 to 20)
237 94 375 63
Respiratory disease 11 (9 to 13) 8 (6 to 10) 7 (6 to 8) 14 (11 to 17)
171 49 130 55
Diseases of the
nervous system
7 (6 to 8) 3 (2 to 4) 6 (5 to 7) 5 (3 to 7)
114 19 105 18
Stroke 7 (6 to 8) 4 (2 to 6) 10 (9 to 11) 11 (8 to 14)
109 24 181 41
Other 23 (21 to 25) 18 (15 to 21) 10 (9 to 11) 15 (11 to 19)
376 112 173 58
Place of death ,.001*
Home 23 (21 to 25) 44 (40 to 48) 46 (44 to 48) 49 (44 to 54)
367 276 846 188
Care home 31 (29 to 33) 18 (15 to 21) 9 (8 to 10) 13 (10 to 16)
499 114 164 48
Hospital 36 (34 to 38) 28 (25 to 31) 39 (37 to 41) 33 (28 to 38)
577 177 716 128
Palliative care unit/
hospice
9 (8 to 10) 10 (8 to 12) 5 (4 to 6) 4 (2 to 6)
150 66 101 17
Other{ 0 0 1 (0.5 to 1.5) 1 (0.005 to 2)
4 1 9 3
CI = confidence interval.
Percentages are within-country percentages. Percentages are rounded and thus may not add up to 100.
Nursing home deaths from the Netherlands (n = 52) were excluded.
Missing values: age n = 12 (0.3%), sex n = 12 (0.3%), place of death n = 15 (0.3%), cause of death n = 53 (1.2%).
*Pearson x2 test.
{Not included in significance tests.
doi:10.1371/journal.pone.0084440.t002
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Table 3. Use of palliative care provided GPs and use of and number of days in specialist palliative care in the last three months of
life; % (95% CI), n.
Belgium Netherlands Italy Spain p-value{
N=1604 N=635 N=1839 N=388
Received specialist palliative care* 47 (44 to 49) 29 (25 to 33) 39 (37 to 41) 45 (40 to 50) ,.001
717 172 683 174
Received palliative care by GP according to GP’s self-
report*
50 (48 to 53) 62 (58 to 65) 55 (53 to 57) 65 (60 to 70) ,.001
807 375 1005 239
In case specialist palliative care was provided N = 717 N = 172 N = 683 N = 174 p-value
Time of initiation of specialist palliative care
Median (IQR) 15 (23) 21 (53) 30 (70) 26 (53) ,.001`
1–3 days 11 (9 to 13) 9 (4 to 13) 3 (2 to 4) 8 (3 to 13) ,.001
78 14 17 11
4–7 days 18 (15 to 21) 18 (12 to 24) 6 (4 to 8) 17 (11 to 23)
127 29 36 23
8–30 days 47 (43 to 51) 38 (31 to 46) 42 (38 to 46) 36 (28 to 45)
330 62 240 50
31–92 days 24 (20 to 27) 35 (28 to 43) 49 (45 to 53) 39 (31 to 47)
165 57 278 53
IQR = inter-quartile range; CI = confidence interval.
Percentages are within-country percentages. Percentages are rounded and thus may not add up to 100.
Missing values: SPC n = 191 (4.3%); time of initiation of SPC n = 174 (3.9% of those who received SPC); palliative care by GP n = 55 (1.2%).
*Palliative care categories are not mutually exclusive.
{p-values based on multivariate analyses adjusted for age, sex, cause and place of death.
`Kruskal-Wallis test (bivariate analysis).
doi:10.1371/journal.pone.0084440.t003
Table 4. Use of specialist palliative care services by country; % (95% CI), n.
Specialist palliative care service* Belgium Netherlands Italy Spain p-value{
N=1604 N=635 N=1839 N=388
Hospice/palliative care unit 11 (10 to 13) 14 (11 to 17) 8 (6 to 9) 17 (13 to 21) ,.001
174 83 132 66
Palliative care service for patients
staying at home
16 (14 to 18) 5 (4 to 7) 24 (22 to 26) 29 (24 to 33) ,.001
250 32| 418 111
GP with formal palliative care training 12 (10 to 15) "
1 74 1 1
In-house palliative care service in a
nursing home
16 (14 to 17) 5 (1 to 8) ,.07`
239 1 1 21
Hospital-based palliative care service (excl.
palliative care unit)
12 (10 to 13) 1 (0.4 to 2) 11 (10 to 13) ,.001
179 8| 196 1
CI = confidence interval.
Percentages are within-country percentages. Percentages are rounded and thus may not add up to 100.
Missing values: specialist palliative care n = 191 (4.3%).
*Palliative care categories are not mutually exclusive.
{p-values are based on multivariate analyses adjusted for age, sex, cause and place of death.
`Statistically significant in bivariate analysis.
1Palliative care initiative not present in this country.
|Palliative care consultation teams in the Netherlands provide services to people at home and in hospital. Our data do not hold information as to where the patients
received this service.
"Comparison between countries not possible.
doi:10.1371/journal.pone.0084440.t004
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Factors Associated with Specialist Palliative Care and
with GPs’ Self-reports of Palliative Care Provision
Results of the multivariate logistic regression analyses indicate
that in all countries, except the Netherlands, a cancer diagnosis
was a significant predictor for receiving specialist palliative care
and for GPs indicating that they provided palliative care to the
patient (Table 5). In the Netherlands this applied only to GPs’
reports of palliative care provision. In Italy and Spain, being
younger than 85 years was associated with higher chances of
receiving specialist palliative care and, in addition, in Italy being
younger than 65 years resulted in lower chances of GPs reporting
that they provided palliative care. Age was not significantly related
to the provision of palliative care by either GPs or palliative care
specialists in Belgium and the Netherlands. According to the GPs’
report, people who died at home were more likely to have received
palliative care by the GP than people who died in other locations
(except for hospice/palliative care unit in Italy and Spain).
Compared with dying at home, dying in hospital was associated
with a lower chance of receiving specialist palliative care in
Belgium and the Netherlands, but not in Italy and Spain.
Factors Associated with Time of Initiation of Specialist
Palliative Care
Ordinal logistic regression analyses revealed that a cancer
diagnosis, compared with a non-cancer diagnosis, was related to
higher chances of an early initiation of specialist palliative care in
Belgium (OR = 1.79 [1.27 to 2.53]) and the Netherlands
(OR = 4.21 [1.90 to 9.30]), but not in Italy and Spain. Dying in
a palliative care unit (OR = 0.59 [0.39 to 0.91]) or a hospital
(OR = 0.44 [0.29 to 0.68]) in Belgium or in a palliative care unit in
Spain (OR = 0.27 [0.07 to 0.97]) was associated with a later
initiation of specialist palliative care compared with dying at home.
Time of initiation of palliative care was not significantly related to
either age or sex in any of the countries, nor to place of death in
the Netherlands and Italy.
Discussion
Of the deaths registered for this study, GPs judged 66% as non-
sudden and expected. This percentage of non-sudden deaths is
consistent with percentages reported by physicians in earlier
studies in six European countries [33–36] but lower than an
estimate obtained in Australia that was based on cause of death
and amounted to 89% of all deaths [46]. The percentage of non-
sudden deaths differed significantly between countries. This was
very likely caused by the exclusion of nursing home deaths from
the Netherlands.
Between half (Belgium) and two-thirds (Spain) of GPs reported
that they had delivered palliative care themselves. According to
GPs’ reports, specialist palliative care was provided to 47% of
patients who died non-suddenly in Belgium, 45% in Spain, 39% in
Italy, and 29% in the Netherlands. GPs in Italy reported the
longest duration of specialist palliative care over the last three
months of life (median 30 days) and GPs in Belgium the shortest
(median 15 days). In the Netherlands and Spain this was 21 and 26
days respectively. In all countries, dying from cancer as opposed to
non-malignant disease emerged as a significant predictor for
receiving specialist palliative care and for the GPs’ self-reports of
palliative care provision, as did being below 85 years of age for
receiving specialist palliative care in Italy and Spain.
As this study was conducted through sentinel networks of GPs it
is important to note that GPs have somewhat different roles in the
health care systems of each of the countries studied. GPs act as
gatekeepers to specialised care in the Netherlands and Spain but
they do not have this role in Belgium and are only partial
gatekeepers in Italy. Despite not being gatekeepers in Belgium,
GPs have an important role in the health care system, and 95% of
the Belgian population have a GP whom they consult regularly
[47]. In all four countries, the vast majority of the population
regularly consult a GP [47–50].
This is one of the first cross-national, population-based studies
to describe and compare the use of palliative care delivered by GPs
and the initiation and use of specialist palliative care among people
who died non-suddenly in four European countries. Through
representative GP networks we obtained, with the exception of
Dutch nursing home deaths, a representative sample of deaths
irrespective of disease, treatment or place of residence. Taking all
non-sudden deaths as the denominator and focusing on the last
three months of life enabled us to study care at the end of life of
those who did and did not receive palliative care and to focus on
care that was actually delivered in the context of dying [34,37].
This study also has limitations. Firstly, although the obtained
percentage of non-sudden deaths is comparable to other studies in
Europe [33–36], inaccuracies in the GPs’ judgment of deaths as
sudden and totally unexpected cannot be fully excluded. Secondly,
it was not possible to validate the information provided by the
sentinel GPs for each registered death against an external criterion
(e.g., hospital registries, insurance data, palliative care registries)
due to the anonymous coding of deaths by the GP networks.
However, the characteristics of the sentinel networks and their
registration procedures, i.e. long-standing experience, weekly
registrations, GPs trained in data collection, consistency checks
of data, support the completeness and accuracy of their reports.
Furthermore, the strength of using sentinel networks of GPs as
observational units is to obtain information not collected in other
databases nor the GPs’ medical files. Thirdly, our data did not
permit us to examine the validity of the GPs’ self-report of
palliative care provision. We could not determine whether the
GPs’ personal definitions of palliative care are consistent with
expert definitions and comparable between countries. It may be
that some GPs label care for a person with a chronic life limiting
illness palliative care whereas others may refer to it as usual GP
care. The results of this study therefore reflect the delivery of what
GPs perceive to be palliative care. Fourthly, due to the
retrospective nature of the data collection, recall bias cannot be
excluded. However, we attempted to limit this by instructing GPs
to register deaths on a weekly basis. Finally, we did not have access
to deaths in nursing homes in the Netherlands where a large
proportion of very old people and people with dementia reside
[51].
Research on palliative care needs has suggested that, given an
ideal state of affairs, every person who dies non-suddenly should
receive palliative care [46]. The results of our study suggest that
varying proportions of people who need palliative care receive it
during the final three months of life in the countries studied. While
our data do not hold information about how many of those who
died non-suddenly without receiving palliative care had actually
needed it, there is evidence that a lack of palliative care service
uptake equates with unmet need, particularly in non-cancer
patients [52]. With regards to our study, this implies that particular
attention should be paid to non-cancer patients who died without
palliative care as they are particularly likely to have unmet needs.
Differences in palliative care provision are likely to reflect
variations in the types of services available as well as the
organisation of palliative care within the respective health care
systems. Looking at specialist palliative care services, the findings
of this study show a particularly high involvement in Belgium and
Spain and a relatively low one in the Netherlands. The fact that
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Table 5. Factors associated with use of palliative care provided by GPs and specialist palliative care services*.
GP palliative care{ Specialist palliative care{
Patient and health care characteristics Received % (n) OR (95% CI) Received % (n) OR (95% CI)
Belgium|| N = 1573 N = 1512
Age p = .872 p = .397
$85 y 54 (329) Ref 42 (251) Ref
65–84 y 47 (349) 0.96 (0.73 to 1.27) 47 (339) 1.16 (0.89 to 1.51)
18–64 y 52 (112) 0.90 (0.59 to 1.36) 56 (114) 1.28 (0.85 to 1.92)
Sex p = .435 p = .297
Male 46 (331) Ref 45 (307) Ref
Female 54 (459) 1.11 (0.86 to 1.43) 48 (397) 1.14 (0.89 to 1.46)
Cause of death p,.001 p,.001
Non-cancer 43 (424) Ref 36 (342) Ref
Cancer 63 (366) 4.60 (3.37 to 6.28) 65 (362) 2.93 (2.24 to 3.85)
Place of death p,.001 p,.001
Home 77 (276) Ref 48 (172) Ref
Care home 69 (338) 1.06 (0.75 to 1.48) 50 (242) 1.72 (1.26 to 2.36)
Hospital 19 (108) 0.07 (0.05 to 0.10) 27 (142) 0.48 (0.36 to 0.65)
Palliative care unit/hospice 46 (68) 0.14 (0.09 to 0.23) 100 (148) 1
Other` 0 (0) 0 (0)
Netherlands|| N = 599 N = 585
Age p = .942 p = .383
$85 y 60 (110) Ref 22 (40) Ref
65–84 y 62 (189) 0.98 (0.59 to 1.64) 32 (94) 1.50 (0.84 to 2.68)
18–64 y 66 (72) 1.09 (0.54 to 2.20) 33 (35) 1.33 (0.62 to 2.83)
Sex p = .064 p = .629
Male 61 (176) Ref 32 (86) Ref
Female 63 (195) 1.51 (0.98 to 2.33) 27 (83) 1.12 (0.71 to 1.78)
Cause of death p,.001 p = .477
Non-cancer 47 (129) Ref 19 (51) Ref
Cancer 75 (242) 2.44 (1.51 to 3.93) 37 (118) 1.22 (0.71 to 2.08)
Place of death p,.001 p = .001
Home 87 (228) Ref 27 (69) Ref
Care home 67 (71) 0.40 (0.22 to 0.73) 20 (22) 0.81 (0.44 to 1.49)
Hospital 20 (33) 0.04 (0.03 to 0.08) 8 (13) 0.25 (0.13 to 0.49)
Palliative care unit/hospice 61 (39) 0.21 (0.11 to 0.39) 100 (65) 1
Other` 0 (0) 0 (0)
Italy|| N = 1777 N = 1709
Age p = .062 p = .001
$85 y 55 (389) Ref 25 (176) Ref
65–84 y 56 (471) 0.93 (0.74 to 1.16) 45 (356) 1.46 (1.12 to 1.89)
18–64 y 53 (119) 0.67 (0.47 to 0.94) 64 (140) 2.02 (1.38 to 2.97)
Sex p = .433 p = .476
Male 55 (459) Ref 42 (341) Ref
Female 55 (520) 1.08 (0.89 to 1.32) 37 (331) 1.09 (0.86 to 1.37)
Cause of death p,.001 p,.001
Non-cancer 48 (462) Ref 19 (174) Ref
Cancer 63 (517) 1.95 (1.57 to 2.43) 63 (498) 5.19 (4.07 to 6.62)
Place of death p,.001 p = .473
Home 63 (515) Ref 35 (277) Ref
Care home 48 (75) 0.59 (0.42 to 0.83) 31 (45) 1.34 (0.88 to 2.04)
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Belgium has the highest ratio of specific palliative care resources
per million inhabitants of the four countries studied might have
contributed to this result [8,11]. Another possible explanation lies
in the relatively high number of hospital deaths in Belgium relative
to the other countries. According to Belgian law, every hospital is
obliged to have a specialist palliative care support team. In
contrast, in the Netherlands where involvement of specialist
palliative care is lowest among the countries studied, a strong
emphasis is put on GPs as being the principal providers of formal
care for terminally ill patients [39,53]. However, the low
percentage in the Netherlands might also partly result from the
exclusion of nursing home deaths.
In the Netherlands and Spain, more GPs reported that they had
provided palliative care compared to Belgium and Italy, possibly
as a result of GPs being gatekeepers to more specialised health care
in these countries. By being the first health care professional to be
consulted by terminally ill patients, GPs may more frequently
deliver palliative care themselves. However, the reason may also
be that the GPs of these two countries are more likely to perceive
the care they provide as palliative care whereas GPs in Italy and
Belgium may view it as usual GP care. This does not mean that
GPs do not have a key role in palliative care in the other two
countries. In Belgium, GPs typically work together with specialist
palliative care services that mainly have an advisory and
supportive role [40]. In Italy GPs typically refer patients to
integrated domiciliary assistance, a home care service managed by
themselves and involving nurses and specialised physicians [49].
The number of patients who received palliative care does not
permit conclusions about the appropriateness of care. The time of
initiation before death, however, may be an indicator of adequacy
as a late referral is often seen as a barrier to achieving the goals of
palliative care [40]. Specialist palliative care appears to start latest
in Belgium which might be a consequence of a Belgian regulation
requiring a life expectancy of between 24 hours and three months
in order for patients receiving palliative care at home to be granted
a ‘palliative lump sum’ from their health insurance, to cover the
costs of medicines, aids, and medical care materials. According to
GPs’ reports, there is a relatively early initiation of specialist
Table 5. Cont.
GP palliative care{ Specialist palliative care{
Patient and health care characteristics Received % (n) OR (95% CI) Received % (n) OR (95% CI)
Hospital 47 (324) 0.53 (0.43 to 0.65) 38 (249) 1.15 (0.90 to 1.46)
Palliative care unit/hospice 64 (65) 0.85 (0.54 to 1.32) 100 (101) 1
Other` 0 (0) 0(0)
GP palliative care Specialist palliative care
Patient and health care characteristics Received n (%) OR (95% CI) Received n (%) OR (95% CI)
Spain|| N = 357 N = 378
Age p = .952 p,.001
$85 y 64 (98) Ref 29 (47) Ref
65–84 y 66 (107) 1.06 (0.63 to 1.79) 54 (92) 2.47 (1.49 to 4.12)
18–64 y 70 (28) 1.15 (0.47 to 2.82) 73 (30) 5.52 (2.29 to 13.33)
Sex p = .363 p = .465
Male 63 (123) Ref 47 (95) Ref
Female 68 (110) 1.25 (0.78 to 2.01) 43 (74) 1.19 (0.75 to 1.90)
Cause of death p = .008 p = .004
Non-cancer 59 (128) Ref 34 (78) Ref
Cancer 76 (105) 2.12 (1.22 to 3.70) 62 (91) 2.08 (1.26 to 3.44)
Place of death p,.001 p = .145
Home 78 (139) Ref 42 (79) Ref
Care home 52 (23) 0.37 (0.18 to 0.75) 47 (21) 1.80 (0.90 to 3.60)
Hospital 51 (61) 0.29 (0.17 to 0.49) 41 (52) 0.75 (0.45 to 1.25)
Palliative care unit/hospice 67 (10) 0.42 (0.13 to 1.36) 100 (17) 1
Other` 0 (0) 0 (0)
OR = odds ratio; CI = confidence interval; Ref = reference category.
All percentages indicate proportions within the independent variable. Percentages are rounded and thus may not add up to 100.
Missing values for dependent variables: specialist palliative care n = 191 (4.3%); GP palliative care n = 55 (1.2%); missing values for independent variables: age n = 12
(0.3%), sex n = 12 (0.3%), cause of death n = 53 (1.2%), place of death n = 15 (0.3%).
Odds ratios in bold indicate statistically significant associations.
Independent variables age and cause of death were correlated (r = .40, p,.01). Variance inflation factors did not indicate problems of multicollinearity.
*Two multivariate logistic regression analyses with 1) palliative care by the GP and 2) specialist palliative care as dependent variable.
{Specialist palliative care and palliative care by the GP are not mutually exclusive categories.
`Not included in significance tests.
1OR not meaningful as 100% of cases have the same value on the dependent variable.
||Missing values on the independent variables resulted in missing cases in the multivariate logistic regression analyses. The number of deaths included in the analyses
are indicated.
doi:10.1371/journal.pone.0084440.t005
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palliative care in Italy and Spain, on the other hand which could
be influenced by the fact that no time limit is set by national health
services for access to palliative care services. However, this result is
somewhat surprising in light of literature suggesting insufficient
communication between doctors and patients concerning diagno-
sis and prognosis in these two countries [54–56].
In all countries except for the Netherlands, a cancer diagnosis
was associated with higher chances of receiving specialist palliative
care and, in Belgium and the Netherlands, with an earlier
initiation. Hence, although efforts are made to extend palliative
care to non-cancer patients, they appear to still be an underserved
group, despite having a symptom burden comparable to that of
people with advanced cancer [57]. However, the proportion of
non-cancer patients receiving palliative care in the countries we
studied was still higher than that in the UK, a country with a
leading role in palliative care, where the proportion of patients
with cancer in palliative care services was estimated to lie between
75% and 90% for the same period [12].
Older patients appear to be underserved with regard to
specialist palliative care in Italy and Spain but not in Belgium
and the Netherlands. There we did not find significant differences
between age groups with regards to receiving palliative care from
either GPs or specialist teams, which is contrary to findings from
earlier studies [16,18]. Increased awareness of palliative care needs
of older people in Belgium and the Netherlands has possibly
contributed to this change. Moreover, our results suggest that GPs
may play an important role in the provision of palliative care to
older people as we did not find a significant association between
the patient’s age and GPs reporting that they delivered palliative
care.
Across countries, home death was relatively consistently
associated with higher chances of receiving specialist palliative
care or GPs reporting to have delivered palliative care. Place of
death was not associated with whether patients received specialist
palliative care in Italy and Spain. However, one must take into
account the possibility that many people who die in hospital in
Italy and Spain are transferred there only shortly before death and
spend the bigger part of the last phase of life at home [14].
Therefore their place of death might not reflect their longest place
of residence.
This study is an important first step towards estimating the
number of people receiving palliative care, and its timing in the
general population of people who die non-suddenly in four
European countries. Given that the number of people living with
and dying of serious chronic diseases is rapidly increasing, a
pressing challenge for future research will be to obtain a better
understanding of the mechanisms through which patient-, care-,
and policy-related factors affect people’s access to and a timely
start of palliative care. This knowledge can then be used to inform
future planning and implementation of targeted measures to
extend palliative care options across patient groups, care settings
and countries.
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